Identifying predictive markers for survival in malignant biliary obstruction following percutaneous transhepatic biliary drainage
Identifying predictive markers for survival in malignant biliary obstruction following percutaneous transhepatic biliary drainage
Aim: malignant biliary obstructive disease is commonly managed with percutaneous transhepatic biliary drainage (PTBD). Traditionally, outcomes are evaluated collectively despite substantial variability in the underlying aetiology and extent of disease. The purpose of this study was to investigate whether variability in survival could be explained by different underlying patient and disease factors.
Materials and methods: a single centre, retrospective study was performed looking at first-time malignant PTBD and respective survival outcomes between 2017- 2021. Survival censoring was taken as June 2022. Predictors included aetiology, age, preprocedural serum haemoglobin, and bilirubin. Subgroups were dichotomised with respect to median values. Kaplan–Meier survival analysis and the log rank test were used for univariate analysis and Cox proportional hazards regression for multivariate analysis.
Results: one hundred fifty-six patients were identified, including 62 pancreatic, 19 ampullary/duodenal, 55 hilar cholangiocarcinoma, and 20 non hepatobiliary cancers. Median overall survival for the entire cohort was 136 days. The underlying aetiology significantly impacted median survival with non-hepatobiliary obstruction faring the worst; 53 days, and was in stark contrast to cholangiocarcinoma (347 days, p < 0.001). On multivariate analysis, we found that in addition to aetiology, patients > 70 years, preprocedural haemoglobin (< 110) and bilirubin (> 232) were all independent prognosticators and had significantly worse survival (HR 1.2, 1.8, 1.6, and 1.4, respectively, all p < 0.05).
Conclusion: age, underlying malignant aetiology, preprocedural haemoglobin, and bilirubin were identified as independent predictors of post-PTBD survival. Careful patient selection may therefore improve patient outcomes following PTBD.
Chan, K.
5c073fda-c489-425d-82bd-bdc8dc23c5f5
Vigneswaran, G.
4e3865ad-1a15-4a27-b810-55348e7baceb
Modi, S.
0726a9d9-714b-48b3-a560-df134b47a04a
Sew Hee, C.
3c87d62e-58f1-4444-85b7-302dca73e0d2
Maclean, D.
c71d2d60-f8f8-43fa-a8d3-a1a8843d8efc
Stedman, B.
e577dc76-bb48-49cc-a722-065ff5645777
Bryant, T.
e95aedb5-e9c9-4f46-a732-ff774b5ea7fd
Maher, B.
a0b818a0-2178-4ba4-bc93-000c68a93e38
Chan, K.
5c073fda-c489-425d-82bd-bdc8dc23c5f5
Vigneswaran, G.
4e3865ad-1a15-4a27-b810-55348e7baceb
Modi, S.
0726a9d9-714b-48b3-a560-df134b47a04a
Sew Hee, C.
3c87d62e-58f1-4444-85b7-302dca73e0d2
Maclean, D.
c71d2d60-f8f8-43fa-a8d3-a1a8843d8efc
Stedman, B.
e577dc76-bb48-49cc-a722-065ff5645777
Bryant, T.
e95aedb5-e9c9-4f46-a732-ff774b5ea7fd
Maher, B.
a0b818a0-2178-4ba4-bc93-000c68a93e38
Chan, K., Vigneswaran, G., Modi, S., Sew Hee, C., Maclean, D., Stedman, B., Bryant, T. and Maher, B.
(2024)
Identifying predictive markers for survival in malignant biliary obstruction following percutaneous transhepatic biliary drainage.
Clinical Radiology, 82, [106772].
(doi:10.1016/j.crad.2024.106772).
Abstract
Aim: malignant biliary obstructive disease is commonly managed with percutaneous transhepatic biliary drainage (PTBD). Traditionally, outcomes are evaluated collectively despite substantial variability in the underlying aetiology and extent of disease. The purpose of this study was to investigate whether variability in survival could be explained by different underlying patient and disease factors.
Materials and methods: a single centre, retrospective study was performed looking at first-time malignant PTBD and respective survival outcomes between 2017- 2021. Survival censoring was taken as June 2022. Predictors included aetiology, age, preprocedural serum haemoglobin, and bilirubin. Subgroups were dichotomised with respect to median values. Kaplan–Meier survival analysis and the log rank test were used for univariate analysis and Cox proportional hazards regression for multivariate analysis.
Results: one hundred fifty-six patients were identified, including 62 pancreatic, 19 ampullary/duodenal, 55 hilar cholangiocarcinoma, and 20 non hepatobiliary cancers. Median overall survival for the entire cohort was 136 days. The underlying aetiology significantly impacted median survival with non-hepatobiliary obstruction faring the worst; 53 days, and was in stark contrast to cholangiocarcinoma (347 days, p < 0.001). On multivariate analysis, we found that in addition to aetiology, patients > 70 years, preprocedural haemoglobin (< 110) and bilirubin (> 232) were all independent prognosticators and had significantly worse survival (HR 1.2, 1.8, 1.6, and 1.4, respectively, all p < 0.05).
Conclusion: age, underlying malignant aetiology, preprocedural haemoglobin, and bilirubin were identified as independent predictors of post-PTBD survival. Careful patient selection may therefore improve patient outcomes following PTBD.
Text
Identifying predictive markers for survival in malignant biliary obstruction following percutaneous transhepatic biliary drainage
- Accepted Manuscript
Restricted to Repository staff only until 14 December 2025.
Request a copy
More information
Accepted/In Press date: 9 December 2024
e-pub ahead of print date: 14 December 2024
Identifiers
Local EPrints ID: 499002
URI: http://eprints.soton.ac.uk/id/eprint/499002
ISSN: 0009-9260
PURE UUID: 462e7f90-6107-40ea-bae5-569038ad0e8e
Catalogue record
Date deposited: 06 Mar 2025 17:53
Last modified: 07 Mar 2025 03:02
Export record
Altmetrics
Contributors
Author:
K. Chan
Author:
S. Modi
Author:
C. Sew Hee
Author:
D. Maclean
Author:
B. Stedman
Author:
T. Bryant
Author:
B. Maher
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics